Voltaren Is Going Generic: What the OTC/Rx Distinction Means for Your PI Clients in 2026

James Wong — Founder & Pharmacist, LienScripts | January 4, 2026 | 7 min read

As brand exclusivity on Voltaren gel fades and generic OTC versions flood pharmacy shelves, PI attorneys need to understand a critical nuance: there are two very different versions of this drug, only one is on LienScripts' standard formulary, and the wrong advice to a client can cost them documentation and out-of-pocket dollars they don't have.

Diclofenac topical gel has been a staple of personal injury treatment plans for years — a targeted NSAID applied directly to the skin over an injured joint or soft tissue site, delivering anti-inflammatory relief with minimal systemic exposure. Attorneys know it as Voltaren. Pharmacists know it in multiple concentrations, formulations, and now, as of the mid-2020s, an increasingly crowded field of generic competitors that are upending how patients, prescribers, and lien programs interact with this medication.

Here is what changed, why it matters for your practice, and exactly how LienScripts handles it.

[!KEY] When a physician prescribes diclofenac gel instead of pointing a client to the OTC shelf, they create a dated pharmacy record linking the medication to the clinical judgment and injury — an OTC purchase creates no such record.

What Happened to Voltaren

Diclofenac sodium gel 1% — sold as Voltaren Gel — completed the transition from prescription-only to over-the-counter in 2020. The FDA approved the OTC switch after determining that the 1% concentration was appropriate for self-directed use by adults for joint pain from arthritis. That switch had a predictable consequence: brand exclusivity on the 1% OTC formulation eventually ends, and generic manufacturers enter the market at significantly lower price points.

By 2026, the landscape looks like this:

• Voltaren Arthritis Pain Gel (1%) — the brand OTC product, sold at retail pharmacies without a prescription
• Generic OTC diclofenac sodium gel 1% — multiple manufacturers, same concentration, available without a prescription, often substantially cheaper than the brand
• Prescription diclofenac — tablets (50 mg, 75 mg, 100 mg extended-release), which remain Rx-only and are the most commonly prescribed form in personal injury cases

OTC vs. Rx: Not Just a Label Difference

The distinction between OTC and prescription diclofenac is not merely regulatory paperwork. The two tracks differ in meaningful ways:

Oral diclofenac tablets remain prescription-only and are the standard starting point for most PI treatment plans involving this drug. The 1% gel is effective for localized use — a knee, a wrist, a shoulder — but a treating physician prescribing it creates very different documentation than a patient buying it off a shelf.

Why "Just Buy It OTC" Is the Wrong Advice for PI Clients

[!TIP] When an adjuster or defense attorney suggests a client "just buy it OTC," push back — a filled prescription creates a pharmacy record that appears in the MERIT report and establishes a causal chain between the accident and the treatment; an OTC receipt does neither.

When a physician recommends diclofenac gel for a PI patient, the path of least resistance seems obvious: the patient can walk into any pharmacy and buy it without a prescription. But this creates two problems.

First, PI clients typically cannot pay out of pocket. Most personal injury clients are uninsured or have insurance that won't touch accident-related medications pending liability resolution. "Just buy it OTC" puts a financial burden on a client who may genuinely be unable to absorb even a modest pharmacy purchase.

Second, an OTC purchase leaves no prescription record. The physician's recommendation exists in the chart note, but the pharmacy record — which shows a dated fill, a dispensing event, a connection between the prescriber and the medication — does not exist. That record matters at settlement. It is the kind of documentation that appears in a MERIT report, that defense counsel reviews when evaluating the demand package, and that establishes a causal chain between the accident and the treatment.

When a physician writes a prescription for diclofenac gel — even the 1% formulation that is commercially available OTC — and that prescription is filled through a pharmacy lien, the patient pays nothing upfront and a full pharmacy record is created.

What LienScripts Covers

Prescription diclofenac (tablets, extended-release) is on LienScripts' standard formulary. A physician writes the prescription, the patient enrolls in the lien program, and the medication fills at any of our 70,000+ participating pharmacies with no upfront cost to the patient.

Prescription diclofenac gel (1%) — even though the same product is available OTC — can also be covered through LienScripts, but it requires a non-formulary exception. The process is straightforward:

1. The treating physician writes a prescription for diclofenac sodium gel 1%, documenting the clinical rationale (localized joint inflammation, targeted delivery to the injury site, preference over systemic NSAIDs given GI or renal considerations, or similar)
2. The prescription is submitted to LienScripts with a brief non-formulary exception request
3. LienScripts reviews and approves coverage, typically within two business days
4. The medication is dispensed through the lien at zero upfront cost to the patient

The non-formulary exception process exists precisely for situations like this — where a clinically appropriate medication falls outside the standard formulary due to a regulatory classification rather than a clinical one. The fact that a drug is available OTC does not mean it is inappropriate for PI lien coverage; it means the prescribing physician's clinical judgment about route of administration, targeted delivery, and documented medical necessity becomes the coverage basis.

Why a Prescription Still Makes Clinical Sense

A physician ordering diclofenac gel rather than pointing a patient to the OTC shelf is making a clinical decision: that this patient's injury warrants a targeted topical anti-inflammatory as part of a documented treatment plan. That decision is worth capturing.

In a typical PI medication regimen, diclofenac gel pairs with oral NSAIDs, muscle relaxants, or neuropathic agents to create a multimodal approach. That combination — and the clinical rationale behind each component — is what MERIT reports are built around. A prescription for diclofenac gel is not redundant just because the 1% product happens to be available without one. It reflects a physician's judgment about this patient's injury.

Defense counsel knows that pharmacy records are contemporaneous evidence. OTC purchases are not. That asymmetry is worth understanding before advising clients on how to fill their medications.

[!KEY] Pharmacy records are contemporaneous evidence; OTC purchase receipts are not — when defense counsel reviews the demand package, a filled prescription for diclofenac creates a dated clinical record, while an OTC receipt creates only a transaction with no connection to any physician or diagnosis.

The Bottom Line for Attorneys

As generic OTC diclofenac gel becomes standard retail shelf inventory, you will encounter more situations where an adjuster, a defense attorney, or even a well-meaning case manager suggests that a client "just pick it up OTC." That suggestion is worth pushing back on:

• If the physician has prescribed it, it can be covered under the pharmacy lien — including through a non-formulary exception if the 1% gel is specified
• Coverage means zero upfront cost to a client who likely cannot pay
• A filled prescription means a pharmacy record, which is worth more at settlement than a receipt from a drugstore checkout line

[!KEY] The non-formulary exception process for prescription diclofenac gel exists precisely for situations where clinical necessity and formulary classification diverge — a physician's documented rationale for the prescription route is the coverage basis, not the product's retail availability.

Contact LienScripts to discuss non-formulary exception requests for OTC diclofenac gel or any other medication where clinical necessity and formulary classification don't match.